Watch CBS News

Mylan CEO on competition

Heather Bresch, who was called before Congress last year to explain why EpiPen's price had soared by nearly 500 percent over seven years, tells Norah O'Donnell why a competing product on the market doesn't necessarily bring prices down.
Jan 27, 2017 (02:35)
View CBS News In
CBS News App Open
Chrome Safari Continue